世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Extra Corporeal Membrane Oxygenation (ECMO) System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others), By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition,  2020-2030F

Extra Corporeal Membrane Oxygenation (ECMO) System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others), By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F


Global Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% thr... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
TechSci Research
テックサイリサーチ
2025年3月28日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
PDF:2営業日程度 184 英語

 

Summary

Global Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% through 2030. The Extracorporeal Membrane Oxygenation (ECMO) System Market is experiencing significant expansion due to the growing demand for advanced life-support technologies in critical care settings. ECMO systems play a crucial role in managing patients with severe cardiac and respiratory failure by providing prolonged extracorporeal circulation and oxygenation. Increased awareness among healthcare professionals regarding the effectiveness of ECMO in improving survival rates has contributed to its widespread adoption. The integration of innovative features such as real-time monitoring, compact designs, and automation is further enhancing system performance and usability. Rising cases of cardiovascular diseases, respiratory disorders, and organ failure are driving the need for ECMO, particularly in intensive care units (ICUs) and specialized cardiac centers. Advancements in medical technologies are also improving patient outcomes, making ECMO a preferred intervention in life-threatening conditions.
Advancements in ECMO technology are reshaping the market, leading to the development of portable and user-friendly systems. Increasing investments in research and development have resulted in devices with enhanced efficiency, reduced complications, and improved patient safety. The growing preference for minimally invasive and percutaneous ECMO cannulation techniques has reduced procedural risks and expanded the applicability of ECMO beyond traditional hospital settings. An increasing number of heart and lung transplant procedures also necessitate the use of ECMO for perioperative support, further driving market growth. The integration of artificial intelligence (AI) and data analytics is helping clinicians monitor and optimize ECMO performance, leading to better patient management. Favorable reimbursement policies in developed countries are enhancing patient access to ECMO therapy, while the growing focus on neonatal and pediatric care is expanding the target patient population. Collaborations between healthcare providers and medical device manufacturers are accelerating the adoption of ECMO systems, particularly in emerging markets where critical care infrastructure is rapidly developing.
Key Market Drivers
Advancements in Medical Technology
Advancements in medical technology have significantly enhanced extracorporeal membrane oxygenation (ECMO) systems, improving their efficacy, safety, and overall utility. These innovations are particularly crucial given the rising prevalence of cardiovascular diseases (CVDs) and respiratory failures, which are leading causes of mortality globally.
In the United States, heart disease remains the leading cause of death, accounting for 702,880 fatalities in 2022, which represents 1 in every 5 deaths. Coronary heart disease (CHD) is the most common type, responsible for 371,506 deaths in the same year. Additionally, about 1 in 20 adults aged 20 and older have CHD. Each year, approximately 805,000 Americans experience a heart attack, with 605,000 being first occurrences and 200,000 happening in individuals who have already had a heart attack.
Key Market Challenges
High Costs and Resource Intensity
ECMO therapy is a highly specialized and resource-intensive medical intervention. The equipment itself is expensive, and the overall cost of ECMO treatment includes not only the machine but also the required disposables, personnel, and infrastructure. Running an ECMO program demands a skilled team of healthcare professionals, including perfusionists and specially trained nurses, as well as dedicated facilities with the necessary technology and expertise.
Financial Burden: The high upfront costs associated with establishing and maintaining an ECMO program can be a substantial financial burden for healthcare institutions, particularly smaller hospitals and clinics. Due to the resource-intensive nature of ECMO, it may not be readily available in all healthcare settings, limiting access for patients in remote areas or regions with fewer healthcare resources. The cost barrier can exacerbate healthcare disparities, as not all patients may have equal access to ECMO treatment, potentially leading to unequal outcomes based on socioeconomic factors.
Key Market Trends
Technological Advancements and Miniaturization
One prominent trend in the global ECMO System Market is the continuous advancement of technology and the development of more compact, portable ECMO systems. This trend aims to make ECMO therapy more accessible and versatile.
Miniaturized ECMO Machines: Manufacturers are working on creating smaller, more portable ECMO machines that are easier to transport and set up. This makes ECMO treatment feasible in a wider range of healthcare settings, including ambulances and remote clinics. ECMO systems are increasingly being integrated with advanced monitoring devices and artificial intelligence algorithms. This integration allows for real-time monitoring of patient vitals, helping healthcare providers make informed decisions and detect complications earlier. Some ECMO systems now offer wireless connectivity, enabling healthcare teams to monitor patients remotely. This feature is especially valuable for critical care patients who require continuous monitoring even during inter-hospital transfers.
Key Market Players
• LivaNova (Alung Technologies Inc.)
• Eurosets
• Getinge AB
• Medtronic PLC
• Microport Scientific Corporation
• Nipro Medical Corporation
• Terumo Medical Corporation
• Abbott Laboratories
• Fresenius Medical Care Company
Report Scope:
In this report, the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Modality:
o Veno-Arterial (VA)
o Veno-Venous (VV)
o Others
• Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Application:
o Respiratory Applications
o Cardiac Applications
o Extracorporeal Cardiopulmonary Resuscitation (ECPR)
• Extra Corporeal Membrane Oxygenation (ECMO) System Market, By End-User:
o Hospitals & Clinics
o Ambulatory Care Centers
o Others
• Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market.
Available Customizations:
Global Extra Corporeal Membrane Oxygenation (ECMO) System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).


ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others)
5.2.2. By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR))
5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Modality
6.2.2. By Application
6.2.3. By End-User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Modality
6.3.1.2.2. By Application
6.3.1.2.3. By End-User
6.3.2. Canada Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Modality
6.3.2.2.2. By Application
6.3.2.2.3. By End-User
6.3.3. Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Modality
6.3.3.2.2. By Application
6.3.3.2.3. By End-User
7. Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Modality
7.2.2. By Application
7.2.3. By End-User
7.3. Europe: Country Analysis
7.3.1. Germany Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Modality
7.3.1.2.2. By Application
7.3.1.2.3. By End-User
7.3.2. United Kingdom Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Modality
7.3.2.2.2. By Application
7.3.2.2.3. By End-User
7.3.3. Italy Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Modality
7.3.3.2.2. By Application
7.3.3.2.3. By End-User
7.3.4. France Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Modality
7.3.4.2.2. By Application
7.3.4.2.3. By End-User
7.3.5. Spain Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Modality
7.3.5.2.2. By Application
7.3.5.2.3. By End-User
8. Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Modality
8.2.2. By Application
8.2.3. By End-User
8.3. Asia-Pacific: Country Analysis
8.3.1. China Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Modality
8.3.1.2.2. By Application
8.3.1.2.3. By End-User
8.3.2. India Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Modality
8.3.2.2.2. By Application
8.3.2.2.3. By End-User
8.3.3. Japan Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Modality
8.3.3.2.2. By Application
8.3.3.2.3. By End-User
8.3.4. South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Modality
8.3.4.2.2. By Application
8.3.4.2.3. By End-User
8.3.5. Australia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Modality
8.3.5.2.2. By Application
8.3.5.2.3. By End-User
9. South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Modality
9.2.2. By Application
9.2.3. By End-User
9.3. South America: Country Analysis
9.3.1. Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Modality
9.3.1.2.2. By Application
9.3.1.2.3. By End-User
9.3.2. Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Modality
9.3.2.2.2. By Application
9.3.2.2.3. By End-User
9.3.3. Colombia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Modality
9.3.3.2.2. By Application
9.3.3.2.3. By End-User
10. Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Modality
10.2.2. By Application
10.2.3. By End-User
10.3. MEA: Country Analysis
10.3.1. South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Modality
10.3.1.2.2. By Application
10.3.1.2.3. By End-User
10.3.2. Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Modality
10.3.2.2.2. By Application
10.3.2.2.3. By End-User
10.3.3. UAE Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Modality
10.3.3.2.2. By Application
10.3.3.2.3. By End-User
11. Market Dynamics
11.1. Drivers & Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market: SWOT Analysis
14. Competitive Landscape
14.5.1. LivaNova (Alung Technologies Inc.)
14.5.2. Eurosets
14.5.3. Getinge AB
14.5.4. Medtronic PLC
14.5.5. Microport Scientific Corporation
14.5.6. Nipro Medical Corporation
14.5.7. Terumo Medical Corporation
14.5.8. Abbott Laboratories
14.5.9. Fresenius Medical Care Company
15. Strategic Recommendations
16. About Us & Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社のヘルスケア分野での最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/08 10:26

148.77 円

163.31 円

192.60 円

ページTOPに戻る